Literature DB >> 16242656

Genes encoding enzymes responsible for biosynthesis of L-lyxose and attachment of eurekanate during avilamycin biosynthesis.

Carsten Hofmann1, Raija Boll, Björn Heitmann, Gerd Hauser, Clemens Dürr, Anke Frerich, Gabriele Weitnauer, Steffen J Glaser, Andreas Bechthold.   

Abstract

The oligosaccharide antibiotic avilamycin A is composed of a polyketide-derived dichloroisoeverninic acid moiety attached to a heptasaccharide chain consisting of six hexoses and one unusual pentose moiety. We describe the generation of mutant strains of the avilamycin producer defective in different sugar biosynthetic genes. Inactivation of two genes (aviD and aviE2) resulted in the breakdown of the avilamycin biosynthesis. In contrast, avilamycin production was not influenced in an aviP mutant. Inactivation of aviGT4 resulted in a mutant that accumulated a novel avilamycin derivative lacking the terminal eurekanate residue. Finally, AviE2 was expressed in Escherichia coli and the gene product was characterized biochemically. AviE2 was shown to convert UDP-D-glucuronic acid to UDP-D-xylose, indicating that the pentose residue of avilamycin A is derived from D-glucose and not from D-ribose. Here we report a UDP-D-glucuronic acid decarboxylase in actinomycetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242656     DOI: 10.1016/j.chembiol.2005.08.016

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  12 in total

1.  Biosynthetic origin and mechanism of formation of the aminoribosyl moiety of peptidyl nucleoside antibiotics.

Authors:  Xiuling Chi; Pallab Pahari; Koichi Nonaka; Steven G Van Lanen
Journal:  J Am Chem Soc       Date:  2011-08-22       Impact factor: 15.419

Review 2.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

3.  The Structure of the Bifunctional Everninomicin Biosynthetic Enzyme EvdMO1 Suggests Independent Activity of the Fused Methyltransferase-Oxidase Domains.

Authors:  C A Starbird; Nicole A Perry; Qiuyan Chen; Sandra Berndt; Izumi Yamakawa; Lioudmila V Loukachevitch; Emilianne M Limbrick; Brian O Bachmann; T M Iverson; Kathryn M McCulloch
Journal:  Biochemistry       Date:  2018-12-07       Impact factor: 3.162

4.  Phylogenetic analysis of antibiotic glycosyltransferases.

Authors:  Dongmei Liang; Jianjun Qiao
Journal:  J Mol Evol       Date:  2007-02-26       Impact factor: 2.395

Review 5.  Enzymes for the biocatalytic production of rare sugars.

Authors:  Koen Beerens; Tom Desmet; Wim Soetaert
Journal:  J Ind Microbiol Biotechnol       Date:  2012-02-14       Impact factor: 3.346

Review 6.  Natural-product sugar biosynthesis and enzymatic glycodiversification.

Authors:  Christopher J Thibodeaux; Charles E Melançon; Hung-wen Liu
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

7.  Oxidative cyclizations in orthosomycin biosynthesis expand the known chemistry of an oxygenase superfamily.

Authors:  Kathryn M McCulloch; Emilianne K McCranie; Jarrod A Smith; Maruf Sarwar; Jeannette L Mathieu; Bryan L Gitschlag; Yu Du; Brian O Bachmann; T M Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

Review 8.  Bioactive oligosaccharide natural products.

Authors:  Emilianne K McCranie; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2014-08       Impact factor: 13.423

9.  Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set.

Authors:  Je Won Park; Jay Sung Joong Hong; Niranjan Parajuli; Won Seok Jung; Sung Ryeol Park; Si-Kyu Lim; Jae Kyung Sohng; Yeo Joon Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-12       Impact factor: 11.205

Review 10.  Microbial Oligosaccharides with Biomedical Applications.

Authors:  Jian-Lin Xu; Zhi-Feng Liu; Xiao-Wei Zhang; Hai-Li Liu; Yong Wang
Journal:  Mar Drugs       Date:  2021-06-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.